Zoledronic acid inhibits the growth of leukemic MLL-AF9 transformed hematopoietic cells.

Acute myeloid leukemia Biochemistry Biological sciences Bisphosphonate Cancer research Cell biology MLL-AF9 gene rearrangement Molecular biology Zoledronic acid

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 05 03 2020
revised: 13 05 2020
accepted: 15 05 2020
entrez: 13 6 2020
pubmed: 13 6 2020
medline: 13 6 2020
Statut: epublish

Résumé

A leukemic

Identifiants

pubmed: 32529062
doi: 10.1016/j.heliyon.2020.e04020
pii: S2405-8440(20)30864-1
pii: e04020
pmc: PMC7283156
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e04020

Informations de copyright

© 2020 The Authors.

Références

Cell Death Dis. 2019 Sep 26;10(10):715
pubmed: 31558698
Ann Pediatr Endocrinol Metab. 2016 Jun;21(2):99-104
pubmed: 27462588
Cell Transplant. 2019 Jan;28(1):129-139
pubmed: 30369260
Sci Rep. 2017 Aug 14;7(1):8090
pubmed: 28808351
Int J Mol Sci. 2018 Dec 14;19(12):
pubmed: 30558116
Br J Haematol. 2009 Mar;144(5):667-76
pubmed: 19036117
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6222s-6230s
pubmed: 17062705
Ann Oncol. 2005 Aug;16(8):1400
pubmed: 15857842
Breast Cancer Res. 2017 Mar 6;19(1):23
pubmed: 28264701
Int J Mol Sci. 2018 Dec 18;19(12):
pubmed: 30567301
Bone. 2011 Jul;49(1):42-9
pubmed: 21281748
Calcif Tissue Int. 2003 Jan;72(1):80-4
pubmed: 12370802
J Bone Oncol. 2014 Feb 18;3(1):10-7
pubmed: 26909293
Oncogene. 2001 Sep 10;20(40):5695-707
pubmed: 11607819
Clin Transplant. 2012 May-Jun;26(3):447-53
pubmed: 22003964
Leukemia. 2013 Apr;27(5):1116-26
pubmed: 23178754
Nat Med. 2005 Aug;11(8):886-91
pubmed: 16025125
Biotechnol Adv. 2012 Jan-Feb;30(1):302-9
pubmed: 21741464
Mol Med Rep. 2016 Dec;14(6):5660-5666
pubmed: 27878279
Blood. 2005 Nov 1;106(9):3134-41
pubmed: 16046524
Br J Haematol. 2005 Aug;130(4):558-60
pubmed: 16098070
ChemMedChem. 2016 Dec 16;11(24):2656-2663
pubmed: 27786425
Molecules. 2018 Aug 17;23(8):
pubmed: 30126100
Leukemia. 2005 Apr;19(4):664-70
pubmed: 15744346
Front Immunol. 2018 May 07;9:984
pubmed: 29867961
J Pediatr Endocrinol Metab. 2014 Mar;27(3-4):349-54
pubmed: 23934636
Anticancer Drugs. 2019 Sep;30(8):821-827
pubmed: 30882399
Clin Interv Aging. 2011;6:89-99
pubmed: 21594000
Leukemia. 2018 Nov;32(11):2326-2338
pubmed: 29740160
Cancer Cell. 2006 Oct;10(4):257-68
pubmed: 17045204
Ther Clin Risk Manag. 2008 Feb;4(1):261-8
pubmed: 18728715
Int J Cancer. 2010 Jan 1;126(1):239-46
pubmed: 19621390
Science. 2007 Apr 27;316(5824):600-4
pubmed: 17463288
PLoS One. 2014 Dec 12;9(12):e114795
pubmed: 25502183
Blood. 2003 Sep 15;102(6):2229-35
pubmed: 12763930
Blood. 2011 Nov 10;118(19):5235-45
pubmed: 21940819
Cancer Cell. 2008 Jun;13(6):483-95
pubmed: 18538732
Cell Cycle. 2008 Nov 1;7(21):3314-9
pubmed: 18948748
Leukemia. 2017 Jan;31(1):258-262
pubmed: 27698446
Apoptosis. 2013 Aug;18(8):963-79
pubmed: 23624644
Proc Natl Acad Sci U S A. 2017 May 23;114(21):5503-5508
pubmed: 28500274
Biomed Pharmacother. 2013 Jul;67(6):527-32
pubmed: 23725755
Int J Pharm. 2017 Jun 30;526(1-2):69-76
pubmed: 28455136
Stem Cell Rev Rep. 2018 Dec;14(6):901-914
pubmed: 29938352
In Vivo. 2016 11-12;30(6):761-768
pubmed: 27815459
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5614-8
pubmed: 11320224
Mediators Inflamm. 2014;2014:318793
pubmed: 24976683
Annu Rev Pathol. 2012;7:283-301
pubmed: 22017583
Eur J Clin Pharmacol. 2008 Oct;64(10):1031-2
pubmed: 18584165
Leuk Res. 2007 Apr;31(4):531-9
pubmed: 16939689
J Proteome Res. 2015 Apr 3;14(4):1888-99
pubmed: 25774781
Oncotarget. 2014 Feb 15;5(3):575-6
pubmed: 24553311
Leukemia. 2005 Nov;19(11):1896-904
pubmed: 16167056
J Cell Biochem. 2013 Jan;114(1):67-78
pubmed: 22833499
Oncotarget. 2017 Jul 4;8(27):43782-43798
pubmed: 28187462
Biomed Pharmacother. 2014 Oct;68(8):1031-6
pubmed: 25312823
Stem Cells. 2016 Jul;34(7):1730-41
pubmed: 26946078
Cancer Lett. 2016 May 28;375(1):162-171
pubmed: 26968247
Biomed Res Int. 2015;2015:165238
pubmed: 26788497
Expert Opin Pharmacother. 2010 Jan;11(1):141-54
pubmed: 20001436
Nat Chem Biol. 2013 Dec;9(12):840-848
pubmed: 24161946

Auteurs

Emanuela Chiarella (E)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Bruna Codispoti (B)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.
Tecnologica Research Institute-Marrelli Health, 88900 Crotone, Italy.

Annamaria Aloisio (A)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Emanuela G Cosentino (EG)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.
Exiris S.r.l., 00128 Roma, Italy.

Stefania Scicchitano (S)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Ylenia Montalcini (Y)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Daniela Lico (D)

Department of Obstetrics & Ginecology, University Magna Græcia, 88100 Catanzaro, Italy.

Giovanni Morrone (G)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Maria Mesuraca (M)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Heather M Bond (HM)

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Dept. of Experimental and Clinical Medicine, University Magna Græcia, 88100 Catanzaro, Italy.

Classifications MeSH